A human cell atlas of fetal gene expression
Quality You Can Trust: Our BPC-157 Complex is manufactured in a state-of-the-art facility, ensuring purity and potency with every dose
Weight regain commonly occurs after stopping GLP-1 therapy, which is why planning this transition with a medical teamrather than stopping abruptly on your ownproduces better outcomes
Perhaps we can make them better by having them not just activate the GLP-1 receptor, but activate other metabolically beneficial receptors as well
Whichever therapy you choose our therapies will help you feel refreshed, rejuvenated and revitalized
If semaglutide made up 80% of GLP-1 volume (before Zepbound), that implies compounded share closer to 32% (source) Now, look at Hims: They launched compounded semaglutide in Q2 2024 and reported $225M in GLP-1 revenue through year-end (source)